Benitec Biopharma Inc. (BNTC) income statement
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.27+0.12 (+1.47%)
Close on Nov 18, 2026Market cap $288.48MP/E –Yield –
Benitec Biopharma Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -33.2%
Financial strength
- Current ratio
- 34.00
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 3367.7%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.63
- Dividend yield
- –
See a number that looks wrong?